These findings, also identified by this present study, have been mentioned in various articles which focus on the benefits of SGLT2i on weight reduction, especially the reduction in visceral adipose tissue, the improvement of hepatic steatosis and metabolic shifts such as the increase in lipolysis and β-oxidation of fatty acids, with a consecutive increase in ketone bodies, with some studies reporting favorable effects on the skeletal muscle insulin sensitivity [66,67,68,69,70]. Here, INS is linked to fatty liver disease.